PHARMACOVIGILANCE Systems in NEPAL PROF. N.R. BISWAS,MD, DM, DNB, DSc Prof. of Clinical Pharmacology & Therapeutics, BPKIHS, Dharan, NEPAL And Govt. of.

Slides:



Advertisements
Similar presentations
Common/shared responsibilities between jobs.
Advertisements

Pre-service component of Integrated Management of Childhood Illness in Nepal Prof. Pushpa Raj Sharma Focal Person.
Institution of Medicine Tribhuvan University. Institute of Medicine (IOM) Established in 1972 in a green field of Maharajgunj, approximately 7 km from.
Dr Sherina Laskar, MD, DNB Resident Physician, Dept of Dermatology&STD
M ONITORING A DVERSE D RUG R EACTIONS (ADR S ) Dr. Dorothy Aywak 1.
THE INAPPROPRIATE SALE OF MEDICATION FOR PEDIATRIC USE IN SIEM REAP PROVINCE, KINGDOM OF CAMBODIA AUTHORS: Sothearith Tiv Ph., Rathi Guhadasan MBBS MRCP.
Abstract The Knowledge, Perceptions, and Practice of Pharmacovigilance among Community Pharmacists in Lagos State, Southwest Nigeria Oreagba, Ibrahim Adekunle.
Drug Hypersensitivity Reaction: DRESS Syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) Christopher Caulfield AM Report December 1, 2009.
Why barcode medications? Admin Rx at the Medical University of South Carolina.
MTP experience to reduce injection overuse in Lao PDR Dr. Amphayvanh Panyanouvong Department of Curative Medicine Ministry of Health, Lao PDR.
Natalie Garcia Anatomy&Physiology 4 th Period. History Of The Disease  First described in 1860 by Ferdinand von Hebra as a severe, self-limiting disorder.
Erythema By Dr. Mohamad Nasr Lecturer Of Dermatology & Venereology.
Clinical pharmacy Dr. Mohammed Al-Rekabi Lecture One First Semester.
General Information JIPMER which includes a tertiary care referral hospital is an Institution of National Importance (an autonomous body) under the Ministry.
Medical Education in Korea and Personal Drug Kyun-Seop Bae MD PhD.
Eureka Pre-Clinical Investigation Animal toxicology Animal pharmacokinetics/ pharmacodynamics Clinical Investigation Phase I Safety and pharmacology Phase.
1 Dermatological Toxicities of ART HAIVN Harvard Medical School AIDS Initiative in Vietnam.
Dr. Sengottuvel Viswanathan Delhi University Delhi.
1 Establishing a Pharmacovigilance Centre Sten Olsson the Uppsala Monitoring Centre.
MG Presentation Rotary Club of Leesburg May 14, 2011.
The South African perspective
Pharmacovigilance Programme of India
Reporting of Adverse Drug Reactions: a study among Clinicians
Pharmacology 3 Safety and Effectiveness in Medicines Administration Applying the Evidence Base.
Sten Olsson WHO Programme Expert Uppsala Monitoring Centre Sweden
Application of Pharmacovigilance in post- marketing traditional Chinese medicine Hua-Wen Xin Wuhan General Hospital, Wuhan, China.
Pharmacology Science that studies interactions of drugs with organism on different levels (subcellular, cellular, organ, systemic) Studies: -relationship.
Emergencies in Pediatric Dermatology Ayelet Shani Adir, M.D. Pediatric Dermatologist Haemek Medical Center.
Utah Emergency Medical Service Discharges Attributed to Opiate Use For Record Years
Author Name: Kannika Inpra Presenter Name: Kannika Inpra Authors: Inpra K., Suwankesawong W., Kaewvichit S. Institution: Phrae.
WWAMI Graduate Medical Education August 10, 2015.
Shuroug Ahmad AlOwais, Pharm.D Teacher assistant WHAT DO YOU KNOW ABOUT PHARMACY.
Definitions. Clinical pharmacy is the branch of Pharmacy where pharmacists provide patient care that optimizes the use of medication and promotes health,
Service Member Receives Vaccine NO REACTION LOCAL REACTION (Occur more often in women than men) Document. Educate. Continue to screen for exclusion criteria.
Dr Shanthi Pal Quality Assurance and Safety of Medicines WHO
State Educational Institution Of Higher Professional Training «Volgograd State Medical University»
Copyright © 2008 Lippincott Williams & Wilkins. Introductory Clinical Pharmacology Chapter 8 Cephalosporins.
Author: Sebabatso C. Mthakathi Presenter: Lineo Maja Faculty of Health Sciences Department of Pharmacy.
Faculty of allied medical sciences (MEST-201). Registration Prof. Ramez Bedwani.
Summary Pattern of Specific COX II Inhibitors Use Physician prescribed appropriate COX II use in high risk was 40.08% and inappropriate COX II use in low.
The Dilemma of Diclofenac Injection for the Iranian Health System Authors: Shalviri G, Cheraghali M, Gholami K, Kamali E, Daryabari N Institution: Ministry.
Dr Mary Couper Quality Assurance and Safety of Medicines WHO
Pharmacovigilance WHO definition
Minimum requirements for Pharmacovigilance in countries.
IMPACT OF TRAINING IN RESPIRATORY GUIDELINES ON IMPROVING USE OF DRUGS Naveen Shrestha Department of Community Medicine and Family Health, IoM, Nepal Louis.
DRUG USE PROFILES IN AN NGO-MANAGED HEALTH CENTRE VERSUS PRIVATE HEALTH PRACTITIONERS Mandal SC: Indian Pharmaceutical Association, Bengal Branch, Kolkata;
PHARMACOVIGILANCE PLAN FOR TANZANIA PREPARED BY EMMA & MARY 10 TH SEPTEMBER 2004.
DOES DRUG USE EVALUATION (DUE) REQUIRED BY NATIONAL POLICY IMPROVE USE OF MEDICINES?
Does Drug Use Evaluation Required by National Policy Improve Use of Medicines? Akaleephan C*, Muenpa R**, Sittitanyakit B***, Treesak C #, Cheawchanwattana.
1 Mobile Health Plus+ Presented by: Amaresh Sahoo (SIMSR, PGDM ) Prashant Gianani (SIMSR, PGDM )
Welcome to Shihezi University Shihezi University is a comprehensive university in Shihezi, a Garden City by the river of Manas, northern foot of the Tianshan.
OBJECTIVES and METHODOLOGY
Detection & monitoring of ADR
The answer to the medical workforce crisis???
Stevens-Johnson Syndrome
Pharmacovigilance Dr. SURENDRA.S.AKASH MD.
Yumi Aoyama and Tetsuo Shiohara
Immunologic Alterations
Erythema multiforme on the palm with target lesions that have a dusky red and white center. (Used with permission from the University of Texas Health Sciences.
Quality Assurance and Safety of Medicines
UNT Health Clinical Pharmacist Services
Kandeke C, Chibuta C, Banda D
Pharmacovigilance workshop
Medicines Safety Mary R. Couper
Cholinesterase Inhibitors: Actions and Uses
Pharmaceutical care plans Ola Ali Nassr
Pharmacovigilance.
How to Fill an ADR Form Dr. Manish Barvaliya, Assistant Professor,
Percentage age distribution of lamotrigine-treated population who experienced Stevens-Johnson syndrome/toxic epidermal necrolysis (cases), patients receiving.
Presentation transcript:

PHARMACOVIGILANCE Systems in NEPAL PROF. N.R. BISWAS,MD, DM, DNB, DSc Prof. of Clinical Pharmacology & Therapeutics, BPKIHS, Dharan, NEPAL And Govt. of India Advisor to BPKIHS, Dharan, NEPAL

Brief History In Nepal, Pharmacovigilance ( ADR reporting ) started in It was mainly due to initiation by Prof. Kumud. K. Kafle of Institute of Medicine, Kathmandu, Nepal

The Department of Drug Administration (DDA), MoHP ( Ministry of Health and Population ) is the focal point of Pharmacovigilance in Nepal.

The (5) regional centers of Pharmacovigilance in Nepal -(1) BPKIHS, Dharan -(2) Institute of Medicine (IOM), Kathmandu -(3) Manipal College of Medical Sciences (MCOMS), Phokhra -(4) Nepal Medical College (NMC), Kathmandu -(5) KIST Medical College, Kathmandu

Total number of ADR cases reported to Department of Drug Administration

Pharmacovigilance Centre, Clinical Pharmacology Department, Institute of Medicine, katmandu 80 cases of adverse drug reactions reported from OPDs and wards of Tribhuban University Teaching Hospital, Katmandu (Nov, 2006 – May, 2010)

Type of ADRs and Number of Cases DrugCases PhenytoinStevens Johnsons Syndrome – 4 Erythroderma – 2 Exanthematous drug rash – 1 Nystagmus – 1 Diplopia, Vomiting – 1 Dizziness – 1 IsoniazidHepatitis – 5 CiprofloxacinErythroderma – 3 Hypersensitivity – 2 Vasculitis – 2 Erythema multiforme – 1 IbuprofenUpper GI bleeding – 3 Toxic epidermal necrolysis – 1 Steven Johnson syndrome (SJS)– 1 Renal impairment – 1

DiclofenacUpper GI bleeding - 4 PenicillinDrug eruption – 3 CotrimoxazoleAngioedema – 1 SJS – 2 Sodium ValproatePancytopenia – 1 Drug eruption – 1 LamotrigineCutaneous drug eruption – 1 Skin rash – 1 AspirinUpper GI bleeding – 1 ParacetamolRash – 1 NaproxenUpper GI bleeding – 1 PrednisoloneAddison’s crisis – 1 Cushingoid syndrome – 1 WarfarinUpper GI bleeding – 1 Coagulopathy – 2 ChloramphenicolPancytopenia – 1 Arthralgia - 1

OTHER ACTIVITIES The department of Clinical Pharmacology, Institute of Medicine, Katmandu also provides following services 1.Drug information unit Question-answering services to the prescribers of TUTH Publication of four issues IN A YEAR of Drug and Therapeutics Letter

2. Drug Monitoring and Toxicology Laboratory Service provided since 1987 Total number of services utilized (July, 2009 – March, 2010) - 757

Future Plannig--- 1.The focal point should encourage regional centers to report cases 2.Regional centers should collect/encourage spontaneous reporting of cases in their institutions 3.The focal point should identify more regional centers

PHARMACOVIGILANCE at BPKIHS, DHARAN Dept of Clinical Pharmacology and Therapeutics is the in –charge of Regional Pharmacovigilance Centre. It is registered as Regional Pharmacovigilance Centre at International Pharmacovigilance Centre, UPPSALA, Sweden, through Dept. of Drug Authority, Katmandu, Nepal.

ACTIVITIES of the Department Collection and monitoring ADR data from various clinical departments Teaching Pharmacovigilance to undergraduate ( MBBS and BDS) students so that the students can be familiar with ADRs. Conducting research on Rational Use of Drugs at BPKIHS and providing feedback to respective departments to prevent ADR

INCIDENCE of ADRs in different Disciplines DISCPLINESNo. of PATIENTS percentages Medicine Surgery35.76 Dermatology Ophthalmology11.92 Pediatrics11.92 Total52100

TYPES of ADRs encountered at BPKIHS Sl.NoName of Drug Types of reaction 1ClonazepamDisorientation, Ataxaia, Dizziness 2CiprofloxacinNausea 3AmlodipineItching 4TriphalaVomiting 5VigoranTingling sensation 6KetoprofenG.I.Bleeding 7AmpicillinMaculopapular rash 8PhenytoinErythematous macules 9DiclofenacErythematous rash, itching 10ChlorpromazineErythematous rash 11MetochlorpromideDystonia 12CotrimoxazoleVomiting, rash, SJS 13PantoprazoleVomiting, 14Promethazine Disorientation

TYPES of ADRs encountered at BPKIHS ( contd.) Sl.NoName of Drug Types of reaction 15PrednisoloneCataract 16DapsoneFever, malaise, Fixed Drug Reaction ( reddish raised lesion) 17ChloramphenicolSteven Johnson Syndrome 18Sulphadoxime+ Pyrimethamine Steven Johnson Syndrome 19FluconazoleBullous Fixeddrug eruption 20SteroidBullous pemphigoid 21ParacetamolMacular papular rash 22NimesulideErythema multiforme 23AllopurinolErythema multiforme 24MorphineThickening of skin

FUTURE PLAN at BPKIHS To do ADR reporting more effective, the Residents and Clinical Faculties will be trained by delivering lectures on ADR. To include zonal hospitals of Eastern Nepal and to train them on how to report ADRs.